Subspecialist neurology · London
Movement disorders clinic, by a subspecialist neurologist.
A private, MDT-backed clinic for Parkinson’s, essential tremor, dystonia, Huntington’s, tics and functional movement disorders. Named consultants at UCLH Private, King’s, HCA The Wellington, Cleveland Clinic London and Imperial Private.
Indicative pricing
What a private movement-disorders clinic costs in London.
In short
£350 to £550, follow-up £220 to £350.
| Service | Indicative range | Typical duration | Turnaround |
|---|---|---|---|
| Initial consultation (45 to 60 minutes) | £350 to £550 | 45 to 60 min | Same visit |
| Follow-up consultation | £220 to £350 | 20 to 30 min | Same visit |
| Botulinum toxin clinic (cervical dystonia, blepharospasm) | £450 to £850 | 30 min | Effect in 5 to 14 days |
| DaTSCAN (SPECT dopamine transporter imaging) | £850 to £1,400 | 3 to 4 hours | 5 to 7 days |
| MRI brain with SWI protocol | £500 to £900 | 30 to 45 min | 3 to 5 days |
| Targeted genetics (GBA, LRRK2, HTT, ATXN panels) | £350 to £900 | Blood draw | 3 to 6 weeks |
Prices vary by consultant, by hospital and by whether investigations, botulinum toxin or genetics are included.
The journey
From referral to follow-up - what happens, in order.
One team from first message to structured follow-up, with a specialist nurse and MDT in the background.
- 04
On the day
Initial consultation, 45 to 60 minutes
A full history, video-recorded neurological examination, MDS-UPDRS scoring where relevant, and a plan for imaging or genetics if diagnostic uncertainty remains.
- 05
On the day
Investigations, same visit or arranged
MRI brain with SWI for iron, DaTSCAN for parkinsonism vs essential tremor, and targeted genetics (GBA, LRRK2, HTT, ATXN) when the phenotype suggests them.
- 06
On the day
Treatment plan and prescription
Levodopa titration, MAO-B inhibitor, dopamine agonist or amantadine, botulinum toxin planning for dystonia, and onward referral for DBS or MRgFUS if indicated.
- 07
After
Follow-up and MDT
A structured follow-up at 6 to 12 weeks, specialist-nurse contact between visits, and joint clinics with physiotherapy, SLT and neuropsychology when useful.
Conditions covered
The full range of hyperkinetic and hypokinetic disorders.
Also seen: drug-induced parkinsonism, restless legs syndrome, hemifacial spasm and paroxysmal dyskinesias.
-
Parkinson’s disease
Rest tremor, bradykinesia, rigidity and postural instability. Levodopa response, non-motor symptoms and advanced-therapy planning.
-
Atypical parkinsonism (PSP, MSA, CBS)
Early falls, vertical gaze palsy, autonomic failure or asymmetric apraxia flag atypical syndromes needing MRI and a careful re-review.
-
Essential tremor
Action and postural tremor of the hands, head or voice. Propranolol, primidone or MRgFUS thalamotomy referral for medication-refractory cases.
-
Dystonia (cervical, blepharospasm, focal)
Cervical dystonia, blepharospasm, hemifacial spasm, writer’s cramp and other task-specific focal dystonias. Botulinum toxin every 12 weeks.
-
Huntington’s disease
Chorea, cognitive change and psychiatric symptoms with a family history. HTT genetic counselling and testing, with MDT support for family members.
-
Tics and Tourette syndrome
Motor and vocal tics from childhood onwards. Habit reversal, comprehensive behavioural intervention and selective medication for disabling tics.
-
Myoclonus, chorea, ataxia
Sudden jerks, dance-like movements or unsteadiness. A systematic search for structural, autoimmune, metabolic and genetic causes.
-
Functional movement disorders
Functional tremor, gait or jerks with positive clinical signs. Explanation, physiotherapy and psychology in a non-stigmatising pathway.
Treatments offered
From levodopa to DBS - a full toolkit, chosen for you.
Medication, botulinum toxin, device-aided therapies (apomorphine, Duodopa) and surgical referral (DBS, MRgFUS), coordinated by the same neurologist and specialist nurse.
-
Levodopa optimisation
Careful titration of co-careldopa or co-beneldopa, timing around meals, and management of wearing-off and dyskinesia with dose fractionation or controlled-release forms.
-
MAO-B inhibitors and agonists
Rasagiline, selegiline or safinamide as adjuncts. Ropinirole, pramipexole or rotigotine patch for younger patients or as add-on, with impulse-control monitoring.
-
Amantadine for dyskinesia
Amantadine immediate- or extended-release for troublesome peak-dose dyskinesia, weighed against cognitive and livedo side effects.
-
Apomorphine and Duodopa
Subcutaneous apomorphine pen or pump, or levodopa-carbidopa intestinal gel via PEG-J, for advanced disease with motor fluctuations. Onward referral to a device-aided therapy centre.
-
Botulinum toxin injections
EMG- or ultrasound-guided botulinum toxin for cervical dystonia, blepharospasm, hemifacial spasm, writer’s cramp and selected tremor syndromes, every 10 to 12 weeks.
-
DBS and MRgFUS referral
Referral for deep brain stimulation (STN, GPi or Vim) or MR-guided focused ultrasound thalamotomy for medication-refractory tremor or Parkinson’s.
-
Physiotherapy and speech therapy
Parkinson’s-specific physiotherapy (LSVT BIG, PD Warrior) and speech and language therapy (LSVT LOUD) for hypophonia, dysarthria and swallowing safety.
-
Second-opinion review
A specialist review of your prior notes, imaging and video, sometimes reassurance, sometimes a change of diagnosis and treatment. £250 to £450.
What to know
Diagnosis, medication and monitoring - honestly.
Early diagnostic uncertainty is normal. Medication has trade-offs. A good clinic is honest about both and reviews you regularly.
-
Diagnostic uncertainty is common early
Early Parkinson’s can look like essential tremor, vascular parkinsonism or drug-induced parkinsonism. A DaTSCAN separates presynaptic dopaminergic loss from mimics.
-
Drug-induced parkinsonism is often missed
Metoclopramide, prochlorperazine, sodium valproate and antipsychotics can cause parkinsonism. A full medication review is part of the first visit.
-
Impulse-control disorders with agonists
Dopamine agonists can trigger pathological gambling, hypersexuality, binge eating or compulsive shopping. Warned about, screened for, and dose-adjusted early.
-
Levodopa is not neurotoxic
Delaying levodopa in the hope of preserving function is not supported by evidence. It is started when symptoms interfere with your work or life, not before, not later.
-
Botulinum toxin is not a permanent fix
Botox lasts 10 to 12 weeks. Neck weakness, dysphagia or ptosis can occur in the first fortnight and settle. Repeat injections keep the effect going.
-
Red flags for atypical parkinsonism
Falls in the first year, early autonomic failure, vertical gaze palsy or rapid cognitive decline should prompt a re-review, MRI and possible referral for atypical syndromes.
-
Genetic testing has real consequences
Predictive HTT testing for Huntington’s is only offered with formal genetic counselling. GBA and LRRK2 results have implications for family members and future trials.
-
Driving and DVLA notification
A diagnosis of Parkinson’s or a movement disorder that affects driving must be notified to the DVLA. DVLA guidance sets out what to declare and when.
-
Restless legs is treatable, not trivial
Restless legs syndrome responds to iron replacement (ferritin target above 75), gabapentinoids or low-dose dopamine agonists. Augmentation with agonists needs vigilance.
Frequently asked
Everything patients commonly ask about movement-disorders clinics.
-
What is a movement-disorders clinic?
A movement-disorders clinic is a subspecialist neurology service for people with hyperkinetic disorders (tremor, dystonia, chorea, tics, myoclonus) and hypokinetic disorders (Parkinson’s disease and atypical parkinsonism). The consultant has a dedicated fellowship-trained practice, uses video-recorded examinations and MDS-UPDRS scoring, and works with a wider MDT of specialist nurses, physiotherapy, speech and language therapy, neuropsychology and neurosurgery.
-
How much does a private movement-disorders consultation cost in London?
An initial consultation with a subspecialist neurologist is typically £350 to £550 for 45 to 60 minutes. Follow-ups are £220 to £350. Botulinum toxin clinics for cervical dystonia or blepharospasm are £450 to £850 per session, including the toxin. DaTSCAN is £850 to £1,400 and MRI brain with SWI is £500 to £900.
-
Do I need a DaTSCAN to diagnose Parkinson’s?
Not always. Parkinson’s disease is a clinical diagnosis. A DaTSCAN is helpful when there is genuine diagnostic uncertainty, for example separating early Parkinson’s from essential tremor, drug-induced parkinsonism or vascular parkinsonism. A normal DaTSCAN in a patient with a clinical picture that looked parkinsonian is called SWEDD and changes the diagnosis and treatment.
-
When should I consider deep brain stimulation or focused ultrasound?
DBS is considered for Parkinson’s with motor fluctuations and dyskinesia despite optimised medication, and for medication-refractory essential tremor or dystonia. MR-guided focused ultrasound thalamotomy is an incisionless alternative for one-sided essential tremor or tremor-dominant Parkinson’s. Both need formal assessment by a specialist centre and are offered on the NHS as well as privately.
-
What is the difference between essential tremor and Parkinson’s tremor?
Essential tremor is an action and postural tremor of the hands (often bilateral), head or voice, worse with movement, sometimes helped by a small amount of alcohol, and often familial. Parkinson’s tremor is a rest tremor, usually asymmetric, with bradykinesia and rigidity on the same side. A careful examination often distinguishes them; a DaTSCAN helps if it does not.
Related
Looking for something more specific?
-
Deep brain stimulation
DBS assessment and referral for Parkinson’s, tremor and dystonia.
Learn more -
Focused ultrasound thalamotomy
Incisionless MRgFUS for essential tremor and tremor-dominant Parkinson’s.
Learn more -
Advanced Parkinson’s therapies
Apomorphine pump and Duodopa (LCIG) for motor fluctuations.
Learn more -
Parkinson’s disease
Diagnosis, medication and MDT care for Parkinson’s.
Learn more -
Essential tremor
Diagnosis and treatment options including MRgFUS and DBS.
Learn more